NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Talkiatry

Talkiatry

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.talkiatry.com/

Last Round

Series D

Feb 12, 2026

Total Funding Raised

$472M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Talkiatry is a mental health care company that provides in-network psychiatry and therapy services through a technology-enabled, human-centered platform.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine, EHR & EMR

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

telepsychiatrymental health servicesin-network psychiatric carevirtual mental healthbehavioral healthelectronic medical recordEMRpsychiatric referralintegrated carevalue-based caremedication managementdigital healthhybrid carewhole-person caretelehealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Talkiatry Comparables

Compare Talkiatry with similar companies based on industry and business-model similarity.

Talkiatry comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brightside Health
86%
Valera Health
84%
Mindpath Health
84%

Talkiatry Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DFeb 12, 2026
Series CJun 18, 2024
Series BJul 1, 2022
Series AJan 27, 2022
Series A ExtensionJul 28, 2021
Series A
Feb 16, 2021

Key People

Founding team and executive leadership

Robert Krayn

Co-Founder CEO

Founding Team

Rachael Kobida

Chief Financial Officer

Executive Team

Christian Freese

Chief Operating Officer

Executive Team

Matt Ivester

Chief Product Officer

Executive Team

Talkiatry Investors

Notable investors and investment history

Talkiatry investors
InvestorRounds
Andreessen HorowitzSeries D, Series C
Perceptive AdvisorsSeries C, Series D
Park VenturesSeries A Extension
Left Lane CapitalSeries D, Series C, Series B, Series A Extension, Series A
blisce/Series D, Series C, Series B
SofinaSeries D
Relevance VenturesSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Delivered over two million patient visits nationwide.

  • Apr 9, 2026

    Launched Talkiatry Connect for faster psychiatric referrals.

Talkiatry Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Talkiatry Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Talkiatry's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range707
Year Founded2019
Last FundingFeb 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.